Optical Coherence Tomography Findings in Lesions After Sirolimus-Eluting Stent Implantation With Peri-Stent Contrast Staining

被引:29
|
作者
Tada, Takeshi [1 ]
Kadota, Kazushige [1 ]
Hosogi, Shingo [2 ]
Kubo, Shunsuke [1 ]
Ozaki, Masatomo [1 ]
Yoshino, Mitsuru [1 ]
Miyake, Koshi [1 ]
Eguchi, Haruki [1 ]
Ohashi, Noriyuki [1 ]
Hayakawa, Yuki [1 ]
Saito, Naoki [1 ]
Otsuru, Suguru [1 ]
Hasegawa, Daiji [1 ]
Shigemoto, Yoshikazu [1 ]
Habara, Seiji [1 ]
Imai, Masao [3 ]
Tanaka, Hiroyuki [1 ]
Fuku, Yasushi [1 ]
Oka, Naoki [1 ]
Kato, Harumi [1 ]
Yamamoto, Hiroyuki [1 ]
Fujii, Satoki [1 ]
Goto, Tsuyoshi [1 ]
Mitsudo, Kazuaki [1 ]
机构
[1] Kurashiki Cent Hosp, Dept Cardiovasc Med, Kurashiki, Okayama 7108602, Japan
[2] Kochi Hlth Sci Ctr, Dept Cardiovasc Med, Kochi, Japan
[3] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan
关键词
peri-stent contrast staining; optical coherence tomography; incomplete stent apposition; multiple interstrut hollows; INTRAVASCULAR ULTRASOUND FINDINGS; BARE-METAL; APPOSITION; THROMBOSIS; HYPERSENSITIVITY; RESTENOSIS; PATTERNS; INSIGHTS;
D O I
10.1161/CIRCINTERVENTIONS.112.968487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-We have sometimes noted abnormal angiographic coronary dilatation, <50% of the reference vessel, at the site of sirolimus-eluting stent implantation, suggesting contrast staining outside the stent struts and named this finding peri-stent contrast staining (PSS). Little was known about optical coherence tomography findings of lesions with PSS. Methods and Results-Between May 2008 and March 2010, we performed optical coherence tomography for 90 in-stent restenosis lesions after sirolimus-eluting stent implantation. We found PSS in 20 of the 90 lesions by coronary angiography. The differences in optical coherence tomography findings, including incomplete stent apposition, multiple interstrut hollows (MIH), strut coverage, and thrombus, were compared between lesions with PSS and those without PSS. PSS is defined as contrast staining outside the stent contour extending to >20% of the stent diameter measured by quantitative coronary angiography. MIH is defined as multiple hollows (the maximum depth >0.5 mm) existing between and outside well-apposed stent struts. Both incomplete stent apposition (60.0% versus 10%; P<0.001) and MIH (85.0% versus 25.7%; P<0.001) were frequently observed in lesions with PSS than in lesions without PSS. Among the 20 lesions with PSS, there was only 1 lesion in which we found neither MIH nor incomplete stent apposition, but only minor dissection. Uncovered struts (11.6% versus 3.9%; P=0.001), malapposed struts (2.0% versus 0.0%; P<0.001), and red thrombus (35% versus 10%; P=0.012) were frequently observed in lesions with PSS than in lesions without PSS. Conclusions-PSS might be closely associated with 2 different optical coherence tomography findings, MIH and incomplete stent apposition, in lesions after sirolimus-eluting stent implantation. (Circ Cardiovasc Interv. 2012;5:649-656.)
引用
下载
收藏
页码:649 / 656
页数:8
相关论文
共 50 条
  • [1] Optical Coherence Tomographic Findings in the Lesions After Sirolimus-Eluting Stent Implantation With Peri-stent Contrast Staining
    Tada, Takeshi
    Kadota, Kazushige
    Kubo, Shunsuke
    Ozaki, Masatomo
    Yoshino, Mitsuru
    Miyake, Koshi
    Eguchi, Haruki
    Ohashi, Noriyuki
    Hayakawa, Yuki
    Saito, Naoki
    Otsuru, Suguru
    Hasegawa, Daiji
    Shigemoto, Yoshikazu
    Habawa, Seiji
    Tanaka, Hiroyuki
    Fuku, Yasushi
    Oka, Naoki
    Kato, Harumi
    Yamamoto, Hiroyuki
    Goto, Tsuyoshi
    Mitsudo, Kazushige
    CIRCULATION, 2011, 124 (21)
  • [2] Peri-stent contrast staining after ultrathin, biodegradable polymer sirolimus-eluting stent implantation: findings from optical coherence tomography and coronary angioscopy
    Yoshitomi, Yuki
    Ikenaga, Hiroki
    Nakano, Yukiko
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2022, 37 (01) : 219 - 220
  • [3] Peri-stent contrast staining after ultrathin, biodegradable polymer sirolimus-eluting stent implantation: findings from optical coherence tomography and coronary angioscopy
    Yuki Yoshitomi
    Hiroki Ikenaga
    Yukiko Nakano
    Cardiovascular Intervention and Therapeutics, 2022, 37 : 219 - 220
  • [4] Evaluation of peri-stent contrast staining and stent fracture after sirolimus-eluting stent implantation by dual source computed tomography
    Miyake, K.
    Yamamoto, H.
    Kadota, K.
    Mitsudo, K.
    EUROPEAN HEART JOURNAL, 2013, 34 : 841 - 841
  • [5] TEMPORAL CHANGE AND MORPHOLOGY OF PERI-STENT CONTRAST STAINING IN LESIONS AFTER EVEROLIMUS-ELUTING STENT IMPLANTATION COMPARED WITH SIROLIMUS-ELUTING STENT IMPLANTATION
    Tada, Takeshi
    Kadota, Kazushige
    Izawa, Yu
    Nakamura, Micihtaka
    Amano, Hidewo
    Ichinohe, Tahei
    Kubo, Shunsuke
    Ozaki, Masatomo
    Hyodo, Yusuke
    Miyake, Koshi
    Hayakawa, Yuki
    Saito, Naoki
    Otsuji, Hideaki
    Hasegawa, Daiji
    Shigemoto, Kazuyoshi
    Habara, Seiji
    Tanaka, Hiroyuki
    Fuku, Yasushi
    Katoh, Harumi
    Yamamoto, Hiroyuki
    Goto, Tsuyoshi
    Mitsudo, Kazuaki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1653 - E1653
  • [6] The relationship between peri-stent contrast staining and positive remodeling after sirolimus-eluting stent implantation assessing with intravascular ultrasound and optical coherence tomography
    Shirasaki, N.
    Tada, T.
    Kadota, K.
    Mitsudo, K.
    EUROPEAN HEART JOURNAL, 2013, 34 : 703 - 703
  • [7] IMPACT OF PLAQUE CHARACTERIZATION ON SUBSEQUENT DEVELOPMENT OF PERI-STENT CONTRAST STAINING AFTER SIROLIMUS-ELUTING STENT IMPLANTATION
    Suzuki, Akihiro
    Ando, Hirohiko
    Takashima, Hiroaki
    Waseda, Katsuhisa
    Asai, Kenji
    Kuhara, Yasushi
    Kuroda, Yasuo
    Kosaka, Takashi
    Kurita, Akiyoshi
    Maeda, Kazuyuki
    Sakurai, Shinichirou
    Kato, Daiki
    Sato, Shigeko
    Fujimoto, Masanobu
    Amano, Tetsuya
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1791 - E1791
  • [8] Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation
    Imai, M.
    Kadota, K.
    Gotou, T.
    Fujii, S.
    Yamamoto, H.
    Fuku, Y.
    Suzuki, N.
    Kouzuma, K.
    Kimura, T.
    Mitsudou, K.
    EUROPEAN HEART JOURNAL, 2011, 32 : 86 - 86
  • [9] Incidence, Risk Factors, and Clinical Sequelae of Angiographic Peri-Stent Contrast Staining After Sirolimus-Eluting Stent Implantation
    Imai, Masao
    Kadota, Kazushige
    Goto, Tsuyoshi
    Fujii, Satoki
    Yamamoto, Hiroyuki
    Fuku, Yasushi
    Hosogi, Shingo
    Hirono, Akitoshi
    Tanaka, Hiroyuki
    Tada, Takeshi
    Morimoto, Takeshi
    Shiomi, Hiroki
    Kozuma, Ken
    Inoue, Katsumi
    Suzuki, Nobuaki
    Kimura, Takeshi
    Mitsudo, Kazuaki
    CIRCULATION, 2011, 123 (21) : 2382 - 2391
  • [10] The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after drug-eluting stent implantation
    Ichinohe, Tahei
    Kadota, Kazushige
    Eguchi, Haruki
    Habara, Seiji
    Tanaka, Hiroyuki
    Tada, Takeshi
    Fuku, Yasushi
    Oka, Naoki
    Yamamoto, Hiroyuki
    Fujii, Satoki
    Goto, Tsuyoshi
    Mitsudo, Kazuaki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B157 - B157